Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Cronos Group Inc. (CRON) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $1.26B, a trailing price-to-earnings ratio of 24.5 and a free-cash-flow yield of 0.0%. Over the most recent reported fiscal year, revenue grew 24.6% and free cash flow per share fell 103.4%.